The role of non-covalent interactions in anticancer drug loading and kinetic stability of polymeric micelles
- 30 April 2012
- journal article
- Published by Elsevier BV in Biomaterials
- Vol. 33 (10), 2971-2979
- https://doi.org/10.1016/j.biomaterials.2011.11.035
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Multifunctional Pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumorsBiomaterials, 2011
- Hydrogen bonding-enhanced micelle assemblies for drug deliveryBiomaterials, 2010
- Polymer micelles with cross-linked polyanion core for delivery of a cationic drug doxorubicinJournal of Controlled Release, 2009
- Self-assembled polymer nanostructures for delivery of anticancer therapeuticsNano Today, 2009
- Complexation and release of doxorubicin from its complexes with pluronic P85-b-poly(acrylic acid) block copolymersJournal of Controlled Release, 2007
- Specific Interactions Improve the Loading Capacity of Block Copolymer Micelles in Aqueous MediaLangmuir, 2007
- Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancerBreast Cancer Research and Treatment, 2007
- Biodegradable cationic PEG–PEI–PBLG hyperbranched block copolymer: synthesis and micelle characterizationBiomaterials, 2005
- Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicinBritish Journal of Cancer, 2004
- Block copolymer micelles for drug delivery: design, characterization and biological significanceAdvanced Drug Delivery Reviews, 2001